A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Kivu Bioscience Inc.
Kestrel Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AbbVie
Eli Lilly and Company
Nammi Therapeutics Inc
National Cancer Institute (NCI)
Bristol-Myers Squibb
Jazz Pharmaceuticals
Revolution Medicines, Inc.
Seagen Inc.
Seagen Inc.
Pfizer
Actuate Therapeutics Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
EMD Serono
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Eli Lilly and Company
Institut Paoli-Calmettes
RasCal Therapeutics, Inc.
Frontier Medicines Corporation
Filamon LTD
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
NeoImmuneTech
Hoffmann-La Roche
ViroMissile, Inc.
University of California, Davis
Massachusetts General Hospital
Erasca, Inc.
Sichuan Enray Pharmaceutical Sciences Company
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Tasca Therapeutics
Essen Biotech
National Institutes of Health Clinical Center (CC)
MBrace Therapeutics
Azienda Ospedaliero-Universitaria di Parma
Revolution Medicines, Inc.
Poseida Therapeutics, Inc.
MacroGenics
Poitiers University Hospital